Short Sellers Raise the Stakes in Cybersecurity
The February 15 short interest data have been compared with the previous figures, and short interest in the selected cybersecurity stocks mostly increased.
All Work
Chris Lange
Short Sellers Take Mixed Stance on Social Media Stocks
Short interest moves in these selected social media stocks were mixed for the most recent settlement date.
Short Sellers Hike Their Bets in Major Biotechs
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Are More Market Highs on the Way After Lower Semiconductor Short Interest?
Semiconductor trends are considered to be leading indicators of technology and broader electronics demand. In a broader sense, semiconductor and tech stocks are considered to be leading indicators for the markets in general. A…
Short Sellers Can’t Make Up Their Minds on Major Oil
The February 15 short interest data have been compared with the previous figures, and short interest moves for the selected oil stocks were mixed.
Why Short Sellers Are Making a Massive Bet in Major Pharma
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Will Warren Buffett Ever Add Amazon to His Portfolio?
The Oracle of Omaha did not have a good answer early on Monday when asked about e-commerce giant Amazon.com. Warren Buffett admitted missing the boat on this one, but will he buy in in…
The Brick Is Back at Nokia: What to Expect
In a blast from the past, Nokia is bringing back the “Brick” or as they call it the 3310. This mobile phone first came out in 2000 and is known as one of the…
How La Jolla’s Low Blood Pressure Treatment Is Driving New Highs
La Jolla Pharmaceutical saw its shares skyrocket on Monday after top-line results from its late-stage study of patients with catecholamine resistant hypotension.
Pickup Sales Take the Top 3 Spots in US Car Sales
Over half a century after its lowly beginnings as a work vehicle, the pickup truck is now the top selling vehicle in the United States.
Why Spirit Ranks Last in Airline Quality
Whenever anyone flies there’s usually a preference for one airline over another, or at least a question of how much quality or convenience is worth in terms of sacrificing for price.
Chinese Supercomputer Set to Shatter World Speed Record
China is looking to breakthrough in 2017 by harnessing high-performance processors and other key technologies to build the world's first prototype exascale supercomputer, the Tianhe-3.
6 Key Earnings to Look For This Week
24/7 Wall St. has put together a preview of Valeant Pharmaceuticals, Salesforce.com and some of the other major companies reporting their quarterly results this week.
Top 9 Retail Earnings Coming Out This Week
The first round of retail earnings has come and gone. Now we are seeing more major retailers getting ready to report.
Top Biopharma Movers of the Past Week
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
How Analysts View Wal-Mart After Earnings
After Wal-Mart reported its fourth-quarter and fiscal 2017 results early on Tuesday, the discount giant saw its shares make a handy gain that day and close out the week up more than 4%.
Why This Key Analyst Is Taking a More Bullish Stance on IBM
IBM has made strides in artificial intelligence with its Watson program, as well as in cloud services. Despite this success, the stock is actually down from its highs back in 2013.
Why Ferrari Is the World’s Most Powerful Auto Brand
In the auto world there is a lot to be said for having a strong reliable brand, especially in an age when people are continuing to grow more dependent on their cars. One firm…
Why the Mobileye Bash Is So Muted
Citron Research is an activist firm known for its infamous short positions over the years. This time Citron is setting its sights on Mobileye.
Is This the Turnaround Cempra Has Been Looking For?
Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections.